Lumigan®/Lumigan® PF (bimatoprost)
Patient Adherence Program (Continuation)
PROGRAM OVERVIEW
This sponsored program aims to provide continued education and support to patients prescribed Lumigan or Lumigan PF eye drops for the treatment of glaucoma.
The program consists of a series of 10 messages delivered over 10 months, with information and topics focused on the quality use of medicines and improving medication adherence and treatment outcomes for patients.
WHEN?
This program launched 13 May 2024.
FOR WHICH PATIENTS?
Messages will be delivered via the app/email or SMS to patients who are signed-up to MedAdvisor, are currently prescribed Lumigan or Lumigan PF eye drops, and have completed the initial Lumigan Patient Adherence Program.
Visit the Digital Adherence Program tile in PlusOne's Health Services Hub to learn more.